All Stories

  1. Mycophenolate mofetil in the treatment of childhood pemphigus vulgaris
  2. Family‐related factors may affect serum vitamin D levels
  3. Poor vaccine-related immunity against HBV in children with autoimmune diseases: Early or late sign of immunological disorder?
  4. Seroprevalence of anti-HEV antibodies in migrants hosted at one shelter in Sardinia
  5. Current Challenges in Neonatal Resuscitation: What is the Role of Adrenaline?
  6. Parasitic hypereosinophilia in childhood: a diagnostic challenge
  7. Multiple glycolytic enzymes are antigens also in biliary atresia
  8. Maternal Carbamazepine Therapy and Unusual Adverse Effects in a Breastfed Infant
  9. Intrahepatic bile duct primary cilia in biliary atresia
  10. Vitamin D deficiency in childhood: old lessons and current challenges
  11. Hepatitis E in Italy: A silent presence
  12. PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
  13. Supraventricular tachycardia during the first year of life: is subclinical inflammation the trigger?
  14. Postnatal Growth in a Cohort of Sardinian Intrauterine Growth-Restricted Infants
  15. Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis?
  16. Pregnancy Outcome among Women with Beta-Thalassemia Major in North Sardinia
  17. Preventing medication errors in neonatology: Is it a dream?
  18. The role of metabolomics in neonatal and pediatric laboratory medicine
  19. Is sucrose useful in neonatal medicine?
  20. Metabolomics in the developing infant
  21. Editorial (Hot Topic: Recent Advances in Neonatal Pharmacology)
  22. Paracetamol (Acetaminophen) Efficacy and Safety in the Newborn
  23. Nenatal Drug Induced Nephrotoxicity : Old and Next Generation Biomarkers for Early Detection and Management of Neonatal Drug-Induced Nephrotoxicity, with Special Emphasis on uNGAL and on Metabolomics
  24. Metabolomics explained to perinatologists and pediatricians
  25. Pharmaceutical research and metabolomics in the newborn
  26. Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
  27. Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates
  28. Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
  29. Clinical application of metabolomics in neonatology
  30. Urinary Metabolomics in Newborns and Infants
  31. Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus
  32. Metabolomics in neonatology and pediatrics
  33. Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure
  34. A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome
  35. Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management
  36. Long-term effects of neonatal drugs on the kidney
  37. Bronchiolitis-associated encephalopathy in critically-ill infants: An underestimated complication?
  38. 1H NMR-based metabolic profiling of urine from children with nephrouropathies
  39. Early diagnosis of acute kidney injury with urinary biomarkers in the newborn
  40. Metabolomics: a new tool for the neonatologist
  41. NSAIDs, prostaglandins and the neonatal kidney
  42. The infant incubator in the neonatal intensive care unit: unresolved issues and future developments
  43. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus
  44. Urinary prostaglandin E2 in the newborn and infant
  45. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?